Damora Therapeutics grants 451,000 inducement stock options at $28.99 per share

Damora Therapeutics granted inducement stock options covering 451,000 ordinary shares to six newly hired, non-executive employees on Aug. 1, 2026.

The options carry a 10-year term with an exercise price of USD 28.99 per share.

Vesting starts with 25% on the first anniversary of each employee’s start date, then continues in monthly installments over the next 36 months.

The awards were issued under the company’s 2022 Inducement Plan with terms set in individual option award agreements.